Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Novo Nordisk Says It Is Gradually Phasing Out Human Insulin Pens Globally
LONDON (Reuters) -Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections. The company declined to comment on the timeline. “Globally…
English